Funding
Seed · Healthtech

Metabolize raises $3.2m seed for metabolic-health products

Astanor led the financing as the company prepares its first consumer product.

By RoundOS Funding desk

Metabolize announced completion of a $3.2 million seed round on October 15, led by Astanor with Maia Ventures, LongGame Venture and SOSV. Funding will support commercialization, product validation and manufacturing.

The San Francisco company plans to launch NatLean in January 2027. The dietary supplement is intended for people transitioning off GLP-1 therapies; the company’s platform draws on exclusively licensed Stanford-originated research.

Funding history

Seed · This round$3.2M

Sources

  1. Metabolize seed announcementprnewswire.com · Oct 15, 2026

Similar rounds

All Healthtech rounds →
Otter Health

Clinical intelligence software helping healthcare payers and providers assess care decisions against evidence and guidelines.

$8MSeed · Oct 15, 2026
Sirona Medical

Cloud radiology software combining image storage, diagnostic viewing, reporting and workflow management.

$40MSeries D · Oct 15, 2026
Sprout Family

An employer benefits platform supporting fertility, family-building, parental leave and return to work.

CA$3.6MSeed · Oct 15, 2026
Abby Care

Abby Care trains and supports eligible family members as paid caregivers, combining nurse-led care management with software that documents care at home.

$82MSeries C · Oct 15, 2026

Related